AstraZeneca says its antibody drug Evusheld can fight Omicron
AstraZeneca said a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron ...
Read moreDetails
AstraZeneca said a lab-study of its COVID-19 antibody cocktail, Evusheld, found that the treatment retained neutralising activity against the Omicron ...
Read moreDetails
The news that a clutch of Bihar’s senior babus may soon head to Delhi on Central deputation, in the wake...
Read moreDetails
The big question being asked 24 hours after US President Donald Trump announced a five-day pause on the ongoing...
Read moreDetails
In a major development on 23 March, US President Donald Trump said in a Truth Social post 23 days after...
Read moreDetails
The world is reeling under an unprecedented fuel and gas crisis. The prevailing situation is creating panic in domestic kitchens,...
Read moreDetails